A multinational Phase 3 registrational trial of Vibegron.
Phase of Trial: Phase III
Latest Information Update: 20 Sep 2017
At a glance
- Drugs Vibegron (Primary)
- Indications Overactive bladder
- Focus Registrational; Therapeutic Use
- Sponsors Urovant Sciences
- 20 Sep 2017 Planned initiation date changed to 1 Jan 2018.
- 18 Sep 2017 According to an Urovant Sciences media release, the company plans to initiate this confirmatory phase III trial by early 2018.
- 19 Jun 2017 New trial record